Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia

Overview of attention for article published in Atherosclerosis (00219150), May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 17 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 25 X posts from 17 X users, with an upper bound of 56,324 followers.

New NNT→Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. https://t.co/gr2UgM6ST3

11 Jul 2020

Reply Repost Favourite

RT @rauldsf_santos: Also SAFEHEART risk equation helps identify higher risk FH individuals! https://t.co/v7e9vMJ9Ai https://t.co/CI0N5jlkd2…

02 Aug 2019

Reply Repost Favourite

RT @rauldsf_santos: Also SAFEHEART risk equation helps identify higher risk FH individuals! https://t.co/v7e9vMJ9Ai https://t.co/CI0N5jlkd2…

02 Aug 2019

Reply Repost Favourite

Also SAFEHEART risk equation helps identify higher risk FH individuals! https://t.co/v7e9vMJ9Ai https://t.co/CI0N5jlkd2 @HFIberoamerica @FHFamiliar

02 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.